Status:
COMPLETED
Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses
Lead Sponsor:
Metabolic Technologies Inc.
Conditions:
Focus of the Study is to Examine Plasma HMB Levels After Oral HMB Supplementation
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the rise in plasma Beta-hydroxy-beta-methylbutyrate (HMB) after the dietary supplement has been administered in different forms. Prior studies have indicated th...
Eligibility Criteria
Inclusion
- Must not be taking amino acid, protein, or HMB supplements; Must not be pregnant; Must not be breastfeeding
Exclusion
- Currently taking amino acid, protein, or HMB supplements; Currently pregnant; Currently breastfeeding
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01914952
Start Date
May 1 2013
End Date
May 1 2014
Last Update
September 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iowa State University
Ames, Iowa, United States, 50014